Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Testosterone may slow down wound healing and increase inflammation.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Male hormones worsen kidney transplant damage, but blocking them helps.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Exosome therapy is more effective than platelet-rich plasma for hair growth in male pattern baldness.

High 1-hour plasma glucose in PCOS increases risks of metabolic issues and gestational diabetes.

Hirsute women have higher testosterone, cholesterol, and glucose levels.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Both methods improve hair density and thickness; double-spin may be more effective.

PHAT may improve hair growth better than PRP alone.

Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Many women with PCOS have abnormal cholesterol levels, needing careful management.